查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1710947

2025年全球植入式心臟裝置市場報告

Implantable Cardiac Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年植入式心臟裝置的市場規模將強勁成長。到 2029 年，這一數字將成長至 188.1 億美元，複合年成長率為 8.7%。預測期內的成長可歸因於設備功能的技術進步、對微創手術的需求增加、老年人口的成長、醫療保健支出的增加以及新興市場的醫療保健基礎設施的擴大。預測期內的關鍵趨勢包括數位健康和​​遠端監控的整合、具有增強功能的下一代設備的開發、個人化和針對患者的心臟解決方案的成長、對成本效益和基於價值的醫療保健的重視、對預防心臟病學和早期療育的日益關注。

心臟病患病率的不斷上升預計將推動植入式心臟設備市場的成長。這種成長可能與多種風險因素有關，包括不健康的飲食、久坐的生活方式、肥胖以及糖尿病和高血壓等慢性疾病。此外，人口老化和壓力水平上升也導致心血管疾病發生率上升。植入式心臟裝置對於控制和治療心臟衰竭、心律不整和冠狀動脈疾病等病症至關重要。對這些設備日益成長的需求正在推動創新和投資，以開發新的和改進的解決方案，以滿足日益成長的患者群體的需求並改善治療結果。例如，2024 年 5 月，新加坡心臟基金會 (SHF) 報告稱，因缺血性心臟疾病死亡的人數為 5,302 人，略高於 2022 年的 5,290 人。因此，心臟病患病率的上升正在推動植入式心臟設備市場的成長。

植入式心臟設備市場的主要企業正致力於提高與 AutoMRI 等診斷工具的兼容性，以延長設備壽命並提高患者安全性。植入式心臟心臟去顫器中的 AutoMRI 功能可自動調整設備設置，以確保 MRI 掃描期間的安全操作，改善患者照護，同時更輕鬆地使用先進的成像技術。例如，2023年10月，法國醫療設備製造商MicroPort CRM在日本推出了其ULYS植入式心臟整流去顫器（ICD）和INVICTA去心房顫動。這些產品採用了先進的技術，具有低電流消耗，可延長設備壽命並具有 MRI 相容性。 ULYS ICD配備PARAD+心律不整辨識演算法和Aut​​MRI功能，INVICTA導線提供精確的起搏和去心房顫動治療，臨床試驗中植入成功率達100%，無併發症率達97.4%。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式心臟裝置 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球植入式心臟裝置市場：成長率分析
  • 全球植入式心臟裝置市場表現：規模與成長，2019-2024
  • 全球植入式心臟裝置市場預測：規模與成長，2024-2029 年，2034 年
  • 植入式心臟設備的全球總目標市場（TAM）

第6章市場區隔

  • 全球植入式心臟設備市場類型、效能及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 心律調節器
  • 植入式心臟整流去顫器（ICD）
  • 雙心室植入式心臟整流去顫器(BI-V ICD)
  • 全球植入式心臟裝置市場：應用、效能及預測，2019-2024 年、2024-2029 年、2034 年
  • 心搏過緩
  • 心搏過速
  • 心臟衰竭
  • 其他用途
  • 全球植入式心臟設備市場（按最終用戶、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 其他最終用戶
  • 全球植入式心臟設備市場心律調節器細分：單室調節器，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 短鏈咪唑寡聚物
  • 長鏈咪唑啉寡聚物
  • 液體肥料溶液
  • 全球植入式心臟設備市場：植入式心臟整流去顫器(ICD) 細分市場（按類型、實際值及預測），2019-2024 年、2024-2029 年、2034 年
  • 靜脈ICD
  • 皮下ICD
  • 心臟去顫器
  • 全球植入式心臟設備市場雙心室植入式心臟整流去顫器(BI-V ICD) 細分市場（按類型、實際值及預測），2019-2024 年、2024-2029 年、2034 年
  • 標準 BI-V ICD
  • 先進的 BI-V ICD 及心臟再同步治療 (CRT)

第7章 區域和國家分析

  • 全球植入式心臟裝置市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式心臟裝置市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 植入式心臟裝置市場：競爭格局
  • 植入式心臟裝置市場：公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Edwards Lifesciences Corporation
  • Biotronik SE & Co. KG
  • Zoll Medical Corporation
  • Nihon Kohden Corporation
  • LivaNova plc
  • Lepu Medical Technology
  • MicroPort Scientific Corporation
  • AtriCure Inc.
  • LifeTech Scientific Corporation
  • Berlin Heart GmbH
  • EBR Systems Inc.
  • Defibtech LLC
  • CVRx Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年植入式心臟設備市場：提供新機會的國家
  • 2029年植入式心臟設備市場：細分市場將帶來新機會
  • 2029年植入式心臟設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31972

Implantable cardiac devices are medical instruments that are surgically inserted into the body to assist in the management of heart disorders, especially those associated with irregular heart rhythms (arrhythmias) or heart failure. These devices monitor cardiac activity and often provide electrical impulses to regulate or correct abnormal heartbeats.

The primary categories of implantable cardiac devices consist of pacemakers, implantable cardioverter defibrillators (ICDs), and biventricular implantable cardioverter defibrillators (BI-V ICDs). A pacemaker is a compact medical device positioned beneath the skin in the chest area, designed to manage irregular heartbeats by delivering electrical impulses that prompt the heart to maintain a normal rhythm when its natural pacemaker is inadequate. This device is essential in treating conditions such as bradycardia and various arrhythmias. Applications for these devices encompass bradycardia, tachycardia, heart failure, among others, catering to end users such as hospitals, specialty clinics, and more.

The implantable cardiac devices market research report is one of a series of new reports from the business research company that provides implantable cardiac devices market statistics, including implantable cardiac devices industry global market size, regional shares, competitors with an implantable cardiac devices market share, detailed implantable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable cardiac devices industry. This implantable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable cardiac devices market size has grown strongly in recent years. It will grow from $12.34 billion in 2024 to $13.46 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to advances in medical technology, increasing prevalence of cardiovascular diseases, growing aging population, improvements in device reliability and longevity, rising awareness, and early diagnosis of heart conditions.

The implantable cardiac devices market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to technological advancements in device functionality, increasing demand for minimally invasive procedures, growing geriatric population, rising healthcare expenditures, and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include integration of digital health and remote monitoring, development of next-generation devices with enhanced features, growth in personalized and patient-specific cardiac solutions, emphasis on cost-effectiveness and value-based healthcare, increasing focus on preventive cardiology, and early intervention.

The increasing prevalence of heart diseases is expected to drive the growth of the implantable cardiac devices market. This rise can be linked to several risk factors, including unhealthy diets, sedentary lifestyles, obesity, and chronic conditions such as diabetes and hypertension. Furthermore, aging populations and elevated stress levels contribute to the higher incidence of cardiovascular issues. Implantable cardiac devices are essential for managing and treating conditions such as heart failure, arrhythmias, and coronary artery disease. The growing need for these devices fosters innovation and investment in the development of new and improved solutions to meet the demands of an expanding patient population and enhance treatment outcomes. For example, in May 2024, the Singapore Heart Foundation (SHF) reported that ischemic heart disease led to 5,302 deaths, a slight increase from 5,290 deaths in 2022. Consequently, the rising incidence of heart disease is propelling the growth of the implantable cardiac devices market.

Key companies in the implantable cardiac devices market are concentrating on improving compatibility with diagnostic tools, such as AutoMRI, to extend device lifespan and enhance patient safety. The AutoMRI feature in implantable cardiac defibrillators automatically adjusts device settings to ensure safe operation during MRI scans, thereby facilitating access to advanced imaging technology while enhancing patient care. For instance, in October 2023, MicroPort CRM, a France-based medical device company, launched the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These products incorporate advanced technology with low current consumption for extended device lifespan and MRI compatibility. The ULYS ICD features the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, while the INVICTA lead provides precise pacing and defibrillation therapy, boasting a 100% implantation success rate and a 97.4% complication-free rate in clinical trials.

In February 2022, Genesis MedTech Group, a Singapore-based medical device manufacturer, acquired JC Medical (JCM) for an undisclosed amount. This acquisition aims to enhance Genesis's product portfolio by adding the J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device designed for patients with aortic regurgitation and stenosis. JC Medical (JCM) is a U.S.-based manufacturer specializing in structural heart devices and cardiac implants.

Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc

North America was the largest region in the implantable cardiac devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable cardiac devices market consists of sales of products including cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and implantable heart monitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardiac Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardiac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardiac devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable cardiac devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Pacemaker; Implantable Cardioverter Defibrillator (ICD); Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
  • 2) By Application: Bradycardia; Tachycardia; Heart Failure; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Other End Users
  • Subsegments:
  • 1) By Pacemaker: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Rate-Responsive Pacemakers
  • 2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs; Subcutaneous ICDs; Wearable Cardioverter Defibrillators
  • 3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs; Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardiac Devices Market Characteristics

3. Implantable Cardiac Devices Market Trends And Strategies

4. Implantable Cardiac Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Implantable Cardiac Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Cardiac Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Cardiac Devices Market Growth Rate Analysis
  • 5.4. Global Implantable Cardiac Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Cardiac Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Cardiac Devices Total Addressable Market (TAM)

6. Implantable Cardiac Devices Market Segmentation

  • 6.1. Global Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pacemaker
  • Implantable Cardioverter Defibrillator (ICD)
  • Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
  • 6.2. Global Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradycardia
  • Tachycardia
  • Heart Failure
  • Other Applications
  • 6.3. Global Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users
  • 6.4. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Pacemaker: Single-Chamber Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Short-Chain Imidazoline Oligomers
  • Long-Chain Imidazoline Oligomers
  • Liquid Fertilizer Solutions
  • 6.5. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transvenous ICDs
  • Subcutaneous ICDs
  • Wearable Cardioverter Defibrillators
  • 6.6. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Biventricular Implantable Cardioverter Defibrillator (BI-V ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard BI-V ICDs
  • Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)

7. Implantable Cardiac Devices Market Regional And Country Analysis

  • 7.1. Global Implantable Cardiac Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Cardiac Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardiac Devices Market

  • 8.1. Asia-Pacific Implantable Cardiac Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardiac Devices Market

  • 9.1. China Implantable Cardiac Devices Market Overview
  • 9.2. China Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardiac Devices Market

  • 10.1. India Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardiac Devices Market

  • 11.1. Japan Implantable Cardiac Devices Market Overview
  • 11.2. Japan Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardiac Devices Market

  • 12.1. Australia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardiac Devices Market

  • 13.1. Indonesia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardiac Devices Market

  • 14.1. South Korea Implantable Cardiac Devices Market Overview
  • 14.2. South Korea Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardiac Devices Market

  • 15.1. Western Europe Implantable Cardiac Devices Market Overview
  • 15.2. Western Europe Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardiac Devices Market

  • 16.1. UK Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardiac Devices Market

  • 17.1. Germany Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardiac Devices Market

  • 18.1. France Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardiac Devices Market

  • 19.1. Italy Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardiac Devices Market

  • 20.1. Spain Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardiac Devices Market

  • 21.1. Eastern Europe Implantable Cardiac Devices Market Overview
  • 21.2. Eastern Europe Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardiac Devices Market

  • 22.1. Russia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardiac Devices Market

  • 23.1. North America Implantable Cardiac Devices Market Overview
  • 23.2. North America Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardiac Devices Market

  • 24.1. USA Implantable Cardiac Devices Market Overview
  • 24.2. USA Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardiac Devices Market

  • 25.1. Canada Implantable Cardiac Devices Market Overview
  • 25.2. Canada Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardiac Devices Market

  • 26.1. South America Implantable Cardiac Devices Market Overview
  • 26.2. South America Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardiac Devices Market

  • 27.1. Brazil Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardiac Devices Market

  • 28.1. Middle East Implantable Cardiac Devices Market Overview
  • 28.2. Middle East Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardiac Devices Market

  • 29.1. Africa Implantable Cardiac Devices Market Overview
  • 29.2. Africa Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardiac Devices Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Cardiac Devices Market Competitive Landscape
  • 30.2. Implantable Cardiac Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardiac Devices Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. B. Braun Melsungen AG
  • 31.3. Edwards Lifesciences Corporation
  • 31.4. Biotronik SE & Co. KG
  • 31.5. Zoll Medical Corporation
  • 31.6. Nihon Kohden Corporation
  • 31.7. LivaNova plc
  • 31.8. Lepu Medical Technology
  • 31.9. MicroPort Scientific Corporation
  • 31.10. AtriCure Inc.
  • 31.11. LifeTech Scientific Corporation
  • 31.12. Berlin Heart GmbH
  • 31.13. EBR Systems Inc.
  • 31.14. Defibtech LLC
  • 31.15. CVRx Inc.

32. Global Implantable Cardiac Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardiac Devices Market

34. Recent Developments In The Implantable Cardiac Devices Market

35. Implantable Cardiac Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Cardiac Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Cardiac Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Cardiac Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer